BookAbhimanyu Garg.
Summary: Dyslipidemias: Pathophysiology, Evaluation and Management provides a wealth of general and detailed guidelines for the clinical evaluation and management of lipid disorders in adults and children. Covering the full range of common through rare lipid disorders, this timely resource offers targeted, practical information for all clinicians who care for patients with dyslipidemias, including general internists, pediatric and adult endocrinologists, pediatricians, lipidologists, cardiologists, internists, and geneticists. For the last twenty years, there has been a growing recognition worldwide of the importance of managing dyslipidemia for the primary and secondary prevention of atherosclerotic vascular disease, especially coronary heart disease. This has been mainly due to the publication of the guidelines of National Cholesterol Education Programs Adult Treatment Panel and Pediatric Panel from the United States. These guidelines have stimulated generation of similar recommendations from all over the world, particularly Europe, Canada, Australia and Asia. Developed by a renowned group of leading international experts, the book offers state-of-the-art chapters that are peer-reviewed and represent a comprehensive assessment of the field. A major addition to the literature, Dyslipidemias: Pathophysiology, Evaluation and Management is a gold-standard level reference for all clinicians who are challenged to provide the best care and new opportunities for patients with dyslipidemias.
Contents:
Lipoprotein Physiology
Epidemiology of Blood Lipids and Lipoproteins
Lipoprotein(a)
Lipoproteins and Cardiovascular Disease Risk
Detection and Treatment of Children and Adolescents with Dyslipidemia
Type 2 Diabetes Mellitus and Dyslipidemia
Type 1 Diabetes Mellitus and Dyslipidemia
Dyslipidemia in Chronic Kidney Disease and Nephrotic Syndrome
Dyslipidemia in HIV-infected Patients
Monogenic Hypercholesterolemia
Primary Hypertriglyceridemia
Genetic Disorders of HDL Metabolism
Sitosterolemia and Other Rare Sterol Disorders
Genetic Abetalipoproteinemia & Hypobetalipoproteinemia
Drug-induced Dyslipidemia
Lipodystrophies and Dyslipidemias
Novel Genes for Dyslipidemias: Genome-Wide Association Studies
Perspectives on Cholesterol Guidelines
Nutrition and Coronary Heart Disease Prevention
Phytosterol Therapy
N-3 Fatty Acids: Role in Treating Dyslipidemias and Preventing Cardiovascular Disease
Polyphenols for Cholesterol Management
Dietary Supplements for Cholesterol Management
Statins: Risk-Benefits and Role in Treating Dyslipidemias
Fibrates: Risk-Benefits and Role in Treating Dyslipidemias
Niacin: Risk-Benefits and Role in Treating Dyslipidemias
Bile Acid Sequestrants: Risk-Benefits and Role in Treating Dyslipidemias
Cholesterol Absorption Inhibitor-Ezetimibe: Risk-Benefits and Role in Treating Dyslipidemias
Low Density Lipoprotein (LDL) Apheresis
Novel Lipid Lowering Agents.